We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management.
- Authors
Greco, M; Crippa, F; Agresti, R; Seregni, E; Gerali, A; Giovanazzi, R; Micheli, A; Asero, S; Ferraris, C; Gennaro, M; Bombardieri, E; Cascinelli, N
- Abstract
Surgical removal of axillary lymph node and histologic examination for metastases are used to determine whether adjuvant treatment is necessary for patients with breast cancer. Axillary lymph node dissection (ALND) is a costly procedure associated with various side effects, and 80% or more of patients with tumors of 20 mm or less are lymph node negative and might avoid ALND. In this study, we evaluated whether an alternative, noninvasive method--i.e., positron emission tomography (PET) with 2-[(18)F]fluoro-2-deoxy-D-glucose (FDG)-- could be used to determine axillary lymph node status in patients with breast cancer.
- Publication
Journal of the National Cancer Institute, 2001, Vol 93, Issue 8, p630
- ISSN
0027-8874
- Publication type
Journal Article
- DOI
10.1093/jnci/93.8.630